SHR-4375
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHR-4375, covering 2025-01-22 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SHR-4375 in Subjects With Solid Tumors [Phase 1, Phase 2]